Harold Rogers Prescription Drug Monitoring Program

 

Goals: To enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data through a centralized database administered by an authorized state agency and federally recognized Indian tribal governments. Objectives: ?Implement and enhance prescription drug monitoring programs. ? Develop and enhance public safety, behavioral health, and public health information sharing partnerships that leverage key public health and public safety data sets (e.g., identified PDMP data, naloxone administrations, fatal and non-fatal overdose data, drug arrests) and develop interventions based on this information.

Active 16.754 Office of Justice Programs, Department of Justice B - Project Grants Fiscal Year 2016 • Currently, 49 states, the District of Columbia, and the U.S. territory of Guam have an operational PDMP. St. Louis County, Missouri’s PDMP is also live. • Missouri has pending state legislation to authorize a PDMP. • Interstate data sharing has expanded significantly in the last two years. Forty states are sharing with at least one other state; nine states are in the process of initiating interstate data sharing; Guam, Hawaii and Oregon are not presently sharing data outside of the state. • 33 states now require prescribers to query the database for all controlled substance prescriptions or under certain circumstances as a result of BJA’s training and technical assistance program in the last three years.
Fiscal Year 2018 • Currently, 49 states, the District of Columbia, and the U.S. territory of Guam have an operational PDMP. 80 percent of Missouri’s counties are also actively contributing data to the PDMP. • Interstate data sharing has expanded significantly in the last two years. All but three states are engaged with interstate data sharing on some level. • All but 8 states and territories require that prescribers or dispensers query the database for controlled substance prescriptions or under certain circumstances. An act appropriating funds for the Department of Justice in the current fiscal year. None. Category 1: Implementation and Enhancement: Applicants are limited to state governments that have a pending or enacted enabling statute or regulation requiring the submission of controlled substance prescription data to an authorized state agency. Category 2: Tribal PDMP Data Sharing Grants: Applicants are limited to federally recognized tribal governments as defined under the Indian Self Determination Act, 25 U.S.C. 450b(e). Category 3: Data-Driven Multidisciplinary Approaches to Reducing Rx Abuse Grants: Applicants are limited to state agencies (health departments, law enforcement authorities, etc.) and units of county government located in states with existing and operational prescription drug monitoring programs. The applicant must submit a completed Application for Federal Assistance (Standard Form 424), including signed assurances that it will comply with statutory and administrative requirements. By certifying on-line, the authorizing signing official is also assuring that all federal certifications and assurances are being met. The certification and assurance forms (Assurances, OJP Form 4000/3 and Certifications Regarding Lobbying; Debarment, Suspension and Other Responsibility Matters; and Drug-Free Workplace Requirements, OJP Form 4061/6) are provided on-line to allow applicants to review and accept them electronically. Preapplication coordination is required. No formal pre application coordination is required. While informal pre application coordination is not required, it is encouraged that applicants coordinate with any facilities for which they have responsibility to detain or incarcerate undocumented criminal aliens. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must submit completed applications via the Office of Justice Programs, Grants Management System or through grants.gov following established criteria. The receipt, review, and analysis of applications will follow Office of Justice Programs policies and procedures for the administration of grant applications. Specific application instructions for solicitations are available at the Office of Justice Programs web site (https://ojp.gov/funding/Explore/CurrentFundingOpportunities). Upon approval by the Assistant Attorney General, successful applicants are notified via the Grants Management System. One copy of the grant award must be signed by the authorized official and returned to the Office of Justice Programs. Contact the headquarters or regional location, as appropriate for application deadlines Applications will generally be approved or denied within 60 days of receipt of a complete application. Not applicable. Not applicable. For selection criteria and required elements see the current fiscal year's solicitation available at the Office of Justice Programs web site at https://ojp.gov/funding/Explore/CurrentFundingOpportunities.htm. The Harold Rogers Prescription Drug Monitoring Program (PDMP) allows for states’ discretion as they plan, implement, or enhance a PDMP to accommodate local decision-making based on state laws and preferences, while encouraging the replication of promising practices. In FY 2012, the program expanded to provide funding to federally recognized Indian tribal governments for the specific purpose of enabling tribal health care providers to provide data to and access data contained within state PDMPs. In FY 2013, the program expanded again to enable applications for data-driven, multidisciplinary approaches to reducing prescription drug abuse, encouraging greater utilization of the PDMPs and their data. In FY 2015 the program added a fourth funding category to promote practitioner and researcher partnerships and contribute to the larger body of knowledge on PDMP best practices. Grant funds under this program can be used to: • Build a state-level data collection and analysis system to enhance the capacity of regulatory and law enforcement agencies and public health officials for future prevention efforts. • Enhance existing programs’ abilities to analyze and use collected data to identify drug abuse trends, identify and address sources of diversion, and increase the number of users of the PDMP. • Promote the use of data from the PDMP and other sources to measure drug abuse trends, identify and address sources of diversion, and better inform decision making by prescribers and dispensers. • Facilitate and participate in national evaluation efforts to assess efficiency and effectiveness of potential best practices. • Encourage and implement the exchange of information under the PMIX Architecture among states to prevent cross-border diversion. • Contribute to state level opioid abuse prevention plans and determine methodologies to encourage replication of strategies that are proven to be effective. • Assess the efficiency and effectiveness of state-level programs to make improvements and encourage additional states to implement programs. • Enhance collaborations with law enforcement, prosecutors, treatment professionals, the medical community, pharmacies, and regulatory boards to establish a comprehensive PDMP strategy. • Enable federally recognized Indian tribal governments to establish the policy, legal, and technological infrastructure to share PDMP data from health care facilities with the appropriate state PDMP. • Establish multidisciplinary action groups consisting of county, state, and federal criminal justice professionals; state and local health authorities; and treatment providers to determine best practices for sharing data, regulatory schemes, deconfliction strategies, intelligence gathering, targeted regulatory and enforcement activity, and prioritization of treatment and prevention efforts for at-risk individuals and communities. Performance Reports: To assist in fulfilling the Departments responsibilities under the Government Performance and Results Act of 1993 (GPRA), Public Law 103-62, and the GPRA Modernization Act of 2010, Public Law 111–352, recipients must provide data that measures the results of their work. Not applicable. In accordance with the requirement set forth in 2 CFR 200, Subpart F, grantees must maintain all financial records, supporting documents, statistical records, and all other records pertinent to the award for at least 3 years following the close of the most recent audit. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. The terms for these grant program budget periods are typically 18 months in duration. See the following for information on how assistance is awarded/release: See the Department of Justice Grants Financial Guide section on “Period of Availability of Funds" at https://ojp.gov/financialguide/DOJ/PostawardRequirements/chapter3.2a.htm. None/Not specified. Tara Kunkel
U.S. Department of Justice
Office of Justice Programs
Bureau of Justice Assistance
810 7th Street, NW
Washington, DC 20531 US
AskBJA@usdoj.gov
Phone: 202-616-6500 or 1-866-859-2647. https://www.bja.gov/ProgramDetails.aspx?Program_ID=72 15-0404-0-1-754 (Project Grants) FY 18$27,278,008.00; FY 19 est $30,000,000.00; FY 20 est $30,000,000.00; FY 17$12,841,705.00; FY 16$11,162,933.00; - See the current fiscal year's solicitation available at the Office of Justice Programs web site (https://ojp.gov/funding/Explore/CurrentFundingOpportunities.htm). Solicitation guidelines are posted on the Office of Justice Programs web site at https://ojp.gov/funding/Explore/CurrentFundingOpportunities.htm . For additional guidance reference the Department of Justice Grants Financial Guide (https://ojp.gov/financialguide/DOJ/index.htm) and Post award Instructions (https://ojp.gov/financialguide/DOJ/PostawardRequirements/index.htm). Fiscal Year 2018 Funding will be provided to add provider dashboard enhancements to the PDMP that support clinical decision-making. Funding will also develop updated training for prescribers, dispensers, and designees on the provider dashboard enhancements and produce updated training videos.
Fiscal Year 2019 The PDMP will employ an epidemiologist to provide data analysis to inform and guide health care practitioners and policy makers and expanding existing outreach and education. The PDMP will also fund integration of PDMP information into clinical workflow by providing mini-grants to small physician practices and independent pharmacies
Fiscal Year 2020 The PDMP will create a statewide data-sharing infrastructure, with a single data repository/database; an interactive web portal accessible by law enforcement, criminal justice, and healthcare stakeholders; and syndromic drug overdose surveillance via dashboards and heat maps. The objectives of the project are to: promote cross-system planning and coordination of opioid use disorder prevention and treatment interventions through information-sharing partnerships with key stakeholders; increase the timeliness, comprehensiveness and reporting of fatal and nonfatal opioid overdose data; disseminate surveillance findings to key stakeholders and policy makers to inform prevention and response efforts; and monitor use of the data-sharing system and implement ongoing quality controls.